- Home
- ECOR vs BODI Comparison
ECOR vs BODI Comparison
Compare ECOR & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- BODI
- Stock Information
- Founded
- ECOR 2005
- BODI 1998
- Country
- ECOR United States
- BODI United States
- Employees
- ECOR N/A
- BODI N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BODI Industrial Machinery/Components
- Sector
- ECOR Health Care
- BODI Industrials
- Exchange
- ECOR Nasdaq
- BODI Nasdaq
- Market Cap
- ECOR 37.1M
- BODI 40.1M
- IPO Year
- ECOR 2018
- BODI N/A
- Fundamental
- Price
- ECOR $4.83
- BODI $6.74
- Analyst Decision
- ECOR Strong Buy
- BODI Buy
- Analyst Count
- ECOR 2
- BODI 2
- Target Price
- ECOR $25.50
- BODI $10.00
- AVG Volume (30 Days)
- ECOR 62.4K
- BODI 14.9K
- Earning Date
- ECOR 11-12-2025
- BODI 11-11-2025
- Dividend Yield
- ECOR N/A
- BODI N/A
- EPS Growth
- ECOR N/A
- BODI N/A
- EPS
- ECOR N/A
- BODI N/A
- Revenue
- ECOR $27,700,000.00
- BODI $324,871,000.00
- Revenue This Year
- ECOR $24.48
- BODI N/A
- Revenue Next Year
- ECOR $44.35
- BODI N/A
- P/E Ratio
- ECOR N/A
- BODI N/A
- Revenue Growth
- ECOR 30.16
- BODI N/A
- 52 Week Low
- ECOR $4.16
- BODI $3.38
- 52 Week High
- ECOR $19.49
- BODI $8.71
- Technical
- Relative Strength Index (RSI)
- ECOR 41.17
- BODI 75.51
- Support Level
- ECOR $4.70
- BODI $5.30
- Resistance Level
- ECOR $5.25
- BODI $6.42
- Average True Range (ATR)
- ECOR 0.26
- BODI 0.41
- MACD
- ECOR 0.01
- BODI 0.07
- Stochastic Oscillator
- ECOR 13.00
- BODI 92.57
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.